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Abstract
Background: S. aureus is an important agent of colonization and infection in liver transplant patients. It harbors
several virulence factors that can increase its pathogenicity. However, studies of virulence and molecular typing of
MRSA in cirrhotic and liver transplantation patients are scarce.
Results: Here we use SCCmec, PFGE, spa typing, MLST and virulence factors to characterize MRSA isolates in pre
and post liver transplantation patients. Sixteen (13 %) of 126 cirrhotic and 15 of the 64 liver-transplanted patients
(23 %) were colonized by MRSA (p = 0.091). SCCmec types I, II and III that are generally associated with nosocomial
infections were identified in 91 % of the isolates. None of the isolates carried PVL, adhesion factors and fib gene.
Only three MRSA colonized isolates carried tst gene and were characterized as SCCmec type I and t149. Ten spa
types and five STs were identified; t002 and ST105 were the most frequent profiles. Spa types and ST1510 never
described in Brazil and a new spa type t14789 were identified. Nineteen PFGE subtypes were found and grouped
into nine types. There was a predominant cluster, which was related to the New York/Japanese epidemic clone and
harboured SCCmec type II identified in both cirrhotic and post-transplantation patients. Based on SCCmec and
virulence factors the MRSA isolates belonged to NY/Jpn clone seen be more similar to the USA100 MRSA isolates.
Conclusions: Although without significance, liver-transplantation was more frequently colonized by MRSA than
cirrhotic patients. The most frequent SCCmec was type II, and the predominant cluster was related to the New
York/Japanese clone. A new spa t14789, and ST1510 never reported in Brazil were identified.
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Background
Methicillin-resistant Staphylococcus aureus (MRSA)
infections rates have been increasing rapidly worldwide
over the past few decades [1]. MRSA is currently
endemic in many hospitals in several countries [1].
According to a SENTRY study, in Brazil, the rates of
MRSA infections are ~30 % and S. aureus is responsible
for ∼ 20 % of nosocomial primary bloodstream infections
(BSIs) [2]. MRSA is an important cause of surgical infec-
tion in liver transplantation patients, increased duration
of hospitalization, costs, morbidity and mortality [3].
Therefore, it is of great importance to understand the
epidemiology of MRSA in this population of patients.
Cirrhotic patients are more frequently colonized by
MRSA than the general population and the burden of
infectious diseases pre and post liver transplantation is
clearly attributable to the dysfunction of defensive mech-
anisms of the host, because of cirrhosis, as well as
because of the use of immunosuppressive agents [4].
Several virulence factors present in S. aureus that allow
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the adherence, colonization and ability to invade tissues
can increase the pathogenicity of this microorganism,
among them the Panton-Valentine leucocidin (PVL), a
toxin that can be able to make pores in the polymorpho-
nuclear cells [5]. However, studies of virulence of MRSA
in cirrhotic and liver transplantation patients are scarce.
Molecular methods such as the characterization of
Staphylococcal Chromosome Cassette mec (SCCmec) by
polymerase chain reaction (PCR), Multi Locus Sequence
Typing (MLST), Pulsed-Field Gel Electrophoresis (PFGE)
and Staphylococcus protein A (Spa) typing had been
developed to evaluate MRSA isolates and to develop strat-
egies to control and prevent colonization and infection.
SCCmec typing is a rapid and easy technique essential for
understanding the molecular epidemiology of MRSA [6].
Another widely used tool is PFGE that has an excellent
discriminatory power and is very useful for epidemio-
logical studies although it is a laborious and time con-
suming technique [7]. Spa typing is a more recent
method based on sequencing the polymorphic region X
or short-sequence repeat (SSR) region of the gene spa.
Changes in the SSR region arise due to deletions, dupli-
cations and point mutations, which results in a diverse
collection of ‘spa types’, where each spa type consists of
a specific combination of SSRs [8]. Spa typing has been
shown to be useful not only for investigation of hospital
outbreaks but also for studies of molecular evolution of
MRSA [8]. The major advantages of spa typing include
it is fast, easy to use, has unambiguous data interpret-
ation and has a standard nomenclature database.
Some studies observed a high concordance between spa
types and PFGE epidemic clones [9, 10]. Golding and col-
leagues showed that the same spa types correspond to mul-
tiple PFGE epidemic clones and require additional
molecular typing to discriminate them. These authors pro-
posed the use of Panton-Valentine leukocidin and SCCmec
typing to differentiate between MRSA isolates that shared
the same spa type but presented multiple PFGE epidemic
types [10]. However, PVL characterization was not able to
differentiate between isolates associated with multiple
PFGE epidemic types, although it can be used as a general
indicator of PFGE epidemic type.
The aim of this study was to compare the use of mo-
lecular methods (SCCmec, PFGE, spa typing and virulence
factors) to characterize MRSA isolates that colonized and




One-hundred and twenty-six outpatients with liver dis-
eases on list waiting for liver transplantation and 64
liver-transplanted patients were evaluated. According to
chart reviews and the questionnaire applied to the 126
listed patients, all patients of list transplantation
reported go to the hospital at least once a month for
doctor visits or routine tests since the discovery of the
disease. Furthermore, 47 (37 %) reported have been
hospitalized in the previous 6 months. In addition, 30
(24 %) patients reported previous use of antimicrobials,
58 (46 %) reported not having used any antimicrobial
previously and 38 (30 %) did not remember about the
use of these drugs in the last 6 months. All liver-
transplanted patients had a 48-hour course of ampicil-
lin plus cefotaxime as antimicrobial prophylaxis and
received tacrolimus and steroid as imunossuprevise
therapy. Those that developed kidney failure had the
therapy replaced by adjusted doses of tacrolimus plus
mycophenolate mofetil (MMF) and steroid.
Demographic and clinical data of the study population
is shown in Table 1. Sixteen patients of the 126 listed out-
patients (13 %) and 15 of the 64 liver-transplanted patients
(23 %) were colonized by MRSA (p = 0.091). Fourteen
patients of list of waiting for liver transplantation were
transplanted during the study and were included between
the 64 liver-transplanted patients. Among then, two were
colonization in pre and post transplantation period and
three were colonization only in post transplantation
period.
Among 64 liver transplanted patients, five had infections
by MRSA (two pneumonias, one infection related to cen-
tral venous line, one blood stream infection and one peri-
tonitis), three of them evoluted to death. Between them,
three patients were colonized in post transplantation
period and two patients were colonized in pre and post
transplantation period. Only one patient with pneumonia
had the same cluster NY/JP in colonization and infection.
Twenty-eight (47 %) liver transplanted patients received
steroid plus tacrolimus and 32 (53 %) MMF plus steroid
and tacrolimus as immunosuppressive therapy, MRSA
colonization was respectively 7 of 28 (46 %) and 8 of 32
(53 %) patients (p = 0.60), data of four patients were not
available.
Isolates
Forty-three isolates from 31 patients were identified as
MRSA. All isolates were positive for the mecA and coA
genes. All isolates were epidemiologically defined as
HA-MRSA.
Only one isolate per patient was selected for further
molecular typing. When patients had MRSA isolates
from the both sites with the same PFGE, the nasal
MRSA isolate was choose for next steps. Furthermore,
one patient showed two phenotypically different MRSA
isolates from the same site and both isolates were
included on the study. Two patients were positives only
in groin and these isolates were evaluated as well.
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A total of 32 isolates were selected for further molecu-
lar typing, which included 16 isolates from patients of
the liver-transplant waiting list and 16 isolates from
liver-transplanted patients.
SCCmec and virulence factors
Among the MRSA isolates, 6 (19 %) carried SCCmec I,
18 (56 %) SCCmec II, 5 (16 %) SCCmec III and 3 (9 %)
SCCmec IVa. SCCmec types that are generally associated
with nosocomial infections (SCCmec types I, II and III)
were identified in 91 % of the HA-MRSA isolates. Of
these, SCCmec type II was the most prevalent type.
None of the isolates carried PVL, adhesion factors such
as exfoliating A, B (eta and etb genes) and fibrinogen
binding protein (fib gene). Three MRSA isolates carried
the tst gene, all isolates were characterized as SCCmec
type I, belonged to cluster E and t0149 and were isolated
from one cirrhotic patient and two liver-transplanted
patients. None of patients carrying tst isolates developed
infections.
Spa typing
Spa typing of the 32 tested MRSA isolates revealed nine
known spa types (t002, t010, t037, t088, t110, t149, t311,
t539 and t3824) and one isolate from a cirrhotic patient
was characterized as a new spa type t14789. This new
spa type presented the following SSR: (r26, r23, r17, r16,
r20, r17, r12, r17, r16), its present a deletion of repeat
and a replacement of r34 by r16 comparing t002, and
was closely related to t311 with a replacement of r34 by
r16. Of these 9 spa types, t002 was the most common,
representing 40.6 % of all isolates.
PFGE
To define the Pulsed-Field types (PFT) obtained by
PFGE, two cutoff levels were considered: >80 % to define
types and 80–95 % to define subtypes. The types were
represented by capital letters and subtypes by numbers.
Between the 32 MRSA isolates, 9 PFGE types and 19
PFGE subtypes were identified. The dendrogram re-
vealed that 13 (41 %) MRSA isolates belonged to a major
cluster, the PFT A, which was related with the
Table 1 Clinical and demographic characteristics of 190 patients before and after liver transplantation undergoing screening for
methicillin-resistant S. aureus (MRSA)
Characteristics Cirrhotic Patients on the waiting list for liver transplantation (126) Liver-transplanted patients (64)





Cirrhosis due to hepatitis C 38 (30 %) 10 (16 %)
Alcoholic cirrhosis 23 (18 %) 8 (12.5 %)
Cryptogenic cirrhosis 13 (10 %) 9 (14 %)
Auto immune hepatites 9 (7 %) 2 (3 %)
Cirrhosis due to hepatitis B 8 (6 %) 3 (5 %)
Sclerosing cirrhosis 5 (4 %) 1 (1.5 %)
Primary biliary cirrhosis 4 (3 %) 1 (1.5 %)
Secondary biliary cirrhosis 3 (2 %) 2 (3 %)
Nash (nonalcoholoic steatohepatitis) 3 (2 %) 1 (1.5 %)
Fulminant hepatites - 4 (6 %)
hepatocellular carcinoma - 3 (5 %)
Unknown cause 4 (3 %) 14 (22 %)
Otherb 14 (11 %) 8 (13 %)
Site of colonization by MRSA
Nasal only 8 (50 %) 9 (60 %)
Groin only 2 (12.5 %) 2 (13 %)
Nasal and groin 6 (37.5 %) 4 (27 %)
aThe total is greater than 100 % because some patients had more than one disease
bOther diseases related: Caroli’s syndrome, schistosomiasis, alpha-1 antitrypsin deficiency, Wilson’s syndrome, biliary atresia, Liver polycystic disease and familial
amyloid polyneuropathy
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representative New York/Japan epidemic clone (NY/Jpn
clone) BK2464, this predominant cloned was identified
in cirrhotic outpatients (n = 8) and in post-
transplantation patients (N = 5) and distributed over a
year period (Fig. 2). Other smaller clusters were noted
(PFT B, C D, E and F, G, H and I). The representative
Brazilian epidemic clone (BEC) HSJ216 was related with
4 (12 %) MRSA isolates with PFT F, all them carried the
same spa type and SCCmec type (t037-SCCmec III) and
were from post transplantation patients. The dendro-
gram, SCCmec, spa type and PFT were represented in
Fig. 1.
The distribution of SCCmec, spa type and PFGE pro-
files among the pre and post transplantation patients
can be seen in Table 2. Distribution of MRSA strains
belonged to the predominant NY/Japanese clone isolated
from cirrhotic and post –transplantation patients over
the study period can be seen in Fig. 2.
MLST
Five Sequence types (ST) were identified. The results of
the MLST for isolates of each PFGE type (A to I) are
presented in Table 3.
Discussion
Previous studies have shown that MRSA colonization in
cirrhotic patients varies from 16 to 28 % and that MRSA
colonization can be associated with a high risk for
Fig. 1 Molecular characteristics of 32 MRSA isolates of cirrhotic and liver transplanted patients from August 2010 to December 2011 (*The strain
BK2464 is representative New York/ Japan epidemic clone. **The strainHSJ216 is representative Brazilian epidemic clone)
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Table 2 Association between molecular typing profiles and epidemic clones, spa types, SCCmec types and virulence factors in









Genes for Virulence factors
PVL TST lukDE fnPA Cirrhotic Liver transplantation
A1 NewYork/Japan clone t002 (7) II (−) (−) (+) (+) 5 2
A1 NewYork/Japan clone t3824 (1) II (−) (−) (+) (+) - 1
A1 NewYork/Japan clone t149 (1) II (−) (−) (+) (+) - 1
A2 NewYork/Japan clone t539 (1) II (−) (−) (+) (+) 1 -
A3 NewYork/Japan clone t088 (1) I (−) (−) (+) (+) - 1
A4 NewYork/Japan clone t002 (1) II (−) (−) (+) (+) 1 -
A5 NewYork/Japan clone t010 (1) II (−) (−) (+) (+) 1 -
B1 t311 (2) II (−) (−) (+) (+) 2 -
B2 t002 (1) II (−) (−) (+) (+) 1 -
C t002 (1) II (−) (−) (+) (+) - 1
D1 t14789 (1) IVa (−) (−) (+) (+) 1
D2 t002 (1) III (−) (−) (+) (+) - 1
D3 t002 (1) IVa (−) (−) (+) (+) - 1
E1 t149 (1) I (−) (+) (+) (+) 1 -
E1 t149 (1) I (−) (+) (−) (+) - 1
E2 t149 (1) I (−) (+) (+) (+) - 1
E3 t088 (1) II (−) (−) (+) (+) - 1
F1 Brazilian clone t037 (2) III (−) (−) (+) (+) - 2
F1 Brazilian clone t037 (1) III (−) (−) (−) (−) - 1
F2 Brazilian clone t037 (1) III (−) (−) (+) (+) - 1
G t110 (2) I (−) (−) (+) (+) 1 1
H t002 (1) II (−) (−) (+) (−) 1 -
I t149 (1) IVa (−) (−) (−) (−) 1 -
Fig. 2 Distribution of MRSA strains belonged to the predominant NY/Japanese clone isolated from cirrhotic and post-transplantation patients over
the study period, from 2010 to 2012
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infection in post liver transplantation patients [11–14].
In spite of this, few studies evaluated the molecular
characterization of MRSA in liver transplantation pa-
tients, most of them described outbreaks, only pvl was
evaluated among the virulence factors, and no study
compared PFGE with spa typing [14–16]. To our know-
ledge, this is the first prospective study of molecular
characterization of MRSA isolates in patients before and
after liver transplantation.
MRSA decolonization has been recommending pre sur-
gery in high risk patients such as cardiac and orthopedic
patients. However, data in liver transplantation is scarce;
most of studies of MRSA carriage in post liver trans-
planted patients were retrospective, evaluated only nares
[13, 17, 18] and the efficacy of pre surgery decolonization
need to be better addressed. In our study, a high propor-
tion of swabbed patients were colonized with MRSA, and
nares were the most frequent site of colonization. We did
not identify outbreak due to MRSA in our hospital during
the study period which might impact the colonization
rates, however, MRSA screening is not performed as
routine in the high risk patients such as intensive care
patients, thus, MRSA colonization was underreported.
A previous study also showed that 236 nares (46 %)
were more positives than rectal cultures (18 %). Based
on our results it seems that there is no need to collected
cultures of other sites besides nares to screening MRSA
in cirrhotic or liver transplanted patient. Although not
significant, in our study liver transplanted patients were
more likely to be colonized by MRSA than cirrhotic
patients (p = 0.091). Thirty-three percent of the MRSA
isolates were from transplanted patients and 17 % of iso-
lates were from cirrhotic patients. However, only three
patients colonized developed infection due to MRSA
post-transplantation, and one patient presented the same
cluster NY/Jpn in colonization and infection. In contrast,
during the period of this study, there were outbreaks by
Gram-negative bacteria in the liver transplantation unit
of our hospital [19]. Interesting, none of patients colo-
nized with MRSA harboring tst gene developed infec-
tions. It seems that the high rate of MRSA colonization
did not increase the rate of infection.
Regarding the molecular typing data we identified nine
different Pulsed Field Types (A-I). The cluster A was
predominant (41 %) and related to the NY/Jpn clone
and present in cirrhotic and liver transplanted patients.
Only 12.5 % of MRSA isolates belonged to BEC that was
identified only in post transplanted patients. Nine known
spa types and a new spa typing (t14789) were identified.
Among them, spa type t002 was the most frequent, six
spa types were associated with the New York/Japan
clone (t002, t010, t088, t149, t539 and t3824) and the
spa type t037 was associated with BEC. These data was
similar with studies that showed that in the last decade,
the New York/Japan clone was highly prevalent in many
Brazilian hospitals [20–23]. In contrast until 2005,
MRSA isolates SCCmec Iva (57 %) and SCCmec type III
belonged to and the Brazilian Endemic Clonal Complex
(BECC) (39 %) were predominant in our hospital [23].
However, since 2010, there was a switched of pattern in
our hospital, MRSA isolates SCCmec II (60 %) with
characteristics of NY/Jpn clone were predominant
instead of MRSA isolates belonged to BEC that repre-
sent only 10 % of isolates [22].
In our study, none of MRSA isolates associated with the
NY/Jpn clone carry tst gene and 92 % harbored SCCmec
II (only one isolate carried SCCmec I). Interestingly, all
MRSA isolates with tst gene carried the same spa type
and SCCmec (t0149 – SCCmec I) but belonged to the dif-
ferent PFT E and differ from Japanase studies [24, 25].
The major MRSA distributed among Japanese hospitals is
New York / Japan clone with SCCmec II and generally
carries the tst gene [24, 25]. However, American studies
showed that isolates of MRSA USA100 (associated with
NY/Jpn clone) harbor SCCmec II and rarely carry tst gene
[24–26]. In view of these results, our MRSA isolates
belonged to NY/Jpn clone seen be more similar to the
USA100 MRSA isolates.
In the present study, only 4 (12,5 %) isolates showed a
pattern closely related to the BEC. All of them had the
same spa type (t037) and SCCmec type III. About the
virulence profile, one isolate did not have the same pattern
of virulence than otherisolates. Although there are few
studies with spa typing in Brazil, our findings are similar
to other Brazilian studies that also found that MRSA iso-
lates t037-SCCmec III were strongly related with Brazilian
epidemic clone [27, 28]. On the other hand, a new spa
type t14789 was identified in our study in a cirrhotic
patient as well as 6 spa types t010, t088, t149, t311, t539 e
t3824 that were identified for the first time in Brazil.
Table 3 Methicilin-resistant Staphylococcus aureus isolates
evaluated as to their MLST. Comparison of Multi Locus
Sequence Typing with PFT and Spa typing of Methicilin-resistant
Staphylococcus aureus isolates over study period, from August
2010 to December 2011
Isolates Body site spa type SCCmec STa PFTb
27 N nasal t002 II ST105 A1
08 N nasal t311 II ST105 B1
P65N nasal t002 II ST105 C
98I groin t14789 IVa ST1176 D1
62 N nasal t149 I ST5 E1
P32N nasal t37 III ST239 F1
78 N nasal t110 I ST105 G
111 N nasal t002 II ST105 H
59 N nasal t149 IVa ST1510 I
aST sequence type, bPulsed-field typing
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This study has several limitations such as it was per-
formed in only one center, the low number of MRSA
infection in the post liver transplantation patients did
not allow us to compare the virulence among colonization
and infection strains and to conduct an intervention study
with decolonization with mupirocin and chlorhexidine
bath. Unfortunately, we could not perform MLST for all
isolates. However, among the STs identified in our study,
ST5, ST105, ST239 and ST1176 had already been
reported in Brazil [21–23, 27–29], including studies in our
Hospital [22, 23]. Nevertheless it was the first description
of ST1510 in Brazil.
In this study, PFGE had a greater discriminatory power
than spa typing. Furthermore, isolates within the same
PFGE cluster had different spa types. Golding and
colleagues [10] developed a large study in Canada with
MRSA isolates and showed that spa types were not lim-
ited to a specific PFGE pattern, and that indistinguishable
PFGE patterns could be of different spa types. These
authors made a more detailed analysis of SSR based on
the degree of similarity of spa types, and showed six-spa
clonal complexes that were related to specific epidemic
clones. Thus, it is possible to suggest that further studies
on the similarity between the SSR are needed to establish
a more reliable correlation between PFGE patterns [10].
Conclusion
In conclusion, a high proportion of patients were colo-
nized with MRSA and nares were the most frequent site
of colonization. Liver-transplantation patients were more
frequently colonized by MRSA than cirrhotic patients.
SCCmec type II was the most frequent SCCmec, and the
predominant clone was related to the NY/Jpn cluster.
PFGE showed a greater discriminatory power than spa
typing. We identified a new spa t14789 and spa types
and ST never reported in Brazil.
Methods
Ethics statement
The study was performed from August 2010 to December
2011 in a university hospital located in São Paulo, Brazil,
the Central Institute of Hospital das Clínicas of University
of São Paulo (ICHC-FMUSP). All patients filled out a
written form agreeing to participate in this study, which
was approved by the ethics committee of “Hospital das
Clinicas” and Medical University of Sao Paulo. The
approval number is 0307/09.
Study design
Prospective observational study, one isolate per patient
was selected for further molecular typing. When patients
showed MRSA isolates from the both sites with the
same PFGE, the nasal MRSA isolate was choose for next
steps.
Population
Nasal and groin swabs were collected from patients on
the waiting list for liver transplantation who came to
medical appointments or were hospitalized in the liver
transplant unit. Swabs of liver-transplanted patients were
also collected on the first day after to surgery or within
48 h after transplantation. Data from nosocomial infec-
tions due to MRSA during hospitalization and until
30 days post-transplantation were evaluated.
All patients agreed to participate in the 335 study.
Demographic and clinical data of patients were collected
by a prior questionnaire and chart reviews. A data base
was build using Epi Info (version 3.5.1), and proportion
of MRSA colonization among cirrhotic and liver trans-
plantation patients was compared using chi-square test,
p value <0.05 was consider significant.
MRSA identification
The swabs (BAC SWAB 1002 DME®) were cultured in
accordance with protocols previously described [30, 31].
Strains were identified as MRSA according to screening
Oxacillin resistance as recommended by CLSI (Clinical
Laboratory Standards Institute) 2010.
DNA extraction
The DNA genomic extraction was performed by Illustra
Bacteria Genomicprep Mini Spin® (Ge Healthcare Life
Science, USA) according to the manufacturer’s
instructions.
Multiplex PCR for Detection of mecA and coA genes
A multiplex PCR (M-PCR) was performed to confirm
methicillin resistance of the S. aureus isolates. The M-
PCR amplifies the coagulase gene coA (intrinsic to S.
aureus) and the mecA gene which confers resistance to
methicillin. PCR was performed according protocol
described previously [32].
Determination of SCCmec
The determination of SCCmec types was performed
using the M-PCR method as described by Zhang et al.
[6], with this method it was possible to determine
SCCmec types I, II, III, IVa, IVb, IVc, IVd and V.
Virulence factors
Specific genes (clfB, fib, fnbPA, eta, etb, luk-DE, pvl and
tst) which encode adhesins and toxins in S. aureus were
identified by M-PCR according to the protocol described
previously [33].
Spa typing
The amplification of the polymorphic region X of the
spa gene was performed with chromosomal DNA puri-
fied from each isolate using primers designed by Shopsin
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and colleagues [8]. The amplified products were sent to
the Human Genome Research Center of University of
São Paulo for sequencing. The sequences were analyzed
using Bioedit software (version 7.2.5; Ibis Biosciences,
CA). Lastly, the spa type was determined using the
online software spaTyper (http://spatyper.fortinbras.us/)
and confirmed on SpaServer database (http://www.spase
rver.ridom.de/) in the National Microbiology Laboratory
of Canada, Winnipeg, Manitoba, Canada.
PFGE
The chromosomal DNA of MRSA isolates was digested
using the restriction enzyme SmaI (Amersham Pharmacia
Biotech, USA). Pulsed-field gel electrophoresis was per-
formed using a CHEF DR-II system (Bio-Rad, USA)
according to previously described [34]. PFGE patterns
were analyzed in Bionumerics version 7.1 (Applied-Maths,
Sint-Martens-Latem, Belgium). DNA fragments were
manually curated and normalized using the molecular
weight standard run on each gel. A 1,5 % band tolerance
and optimization of 0,5 % was selected for use during
comparisons of DNA profiles as suggested by Mulvey and
colleagues [35]. Cluster analysis was performed by the
unweighted pair group method using arithmetic averages
(UPGMA). Isolates were considered to be genetically
related if Dice coefficient correlation was >80 %. DNA
fragments of the strains BK2464 and HSJ216 (representa-
tive of New York/Japan epidemic clone and Brazilian epi-
demic clone, respectively) were included to comparisons
of DNA profiles according to PFGE patterns previously
generated by Oliveira and colleagues [34].
MLST
Nine isolates were selected, one isolate of each PFT to per-
formed MLST profiles according to procedures published
elsewhere [36]. The sequences of seven housekeeping genes
(arcC, aroE, glpF, gmk, pta, tpi and yqiL) were compared to
existing sequences in the MLST database (http://
www.mlst.net) for the assignment of allelic numbers.
Sequence types (ST) were assigned according to their allelic
profiles.
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